Pharmacokinetics of Levodopa and 3-O-Methyldopa in Parkinsonian Patients Treated with Levodopa and Ropinirole and in Patients with Motor Complications

Parkinson’s disease (PD) is a progressive, neurodegenerative disorder primarily affecting dopaminergic neuronal systems, with impaired motor function as a consequence. The most effective treatment for PD remains the administration of oral levodopa (LD). Long-term LD treatment is frequently associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamiak-Giera, Urszula, Jawień, Wojciech, Pierzchlińska, Anna, Białecka, Monika, Kobierski, Jan Dariusz, Janus, Tomasz, Gawrońska-Szklarz, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472364/
https://www.ncbi.nlm.nih.gov/pubmed/34575471
http://dx.doi.org/10.3390/pharmaceutics13091395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472364/
https://www.ncbi.nlm.nih.gov/pubmed/34575471
http://dx.doi.org/10.3390/pharmaceutics13091395

Ejemplares similares